Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9637-41. doi: 10.1073/pnas.95.16.9637.

Abstract

Families bearing mutations in the presenilin 1 (PS1) gene develop Alzheimer's disease. Previous studies have shown that the Alzheimer-associated mutations in PS1 increase production of amyloid beta protein (Abeta1-42). We now show that PS1 also regulates phosphorylation of the microtubule-associated protein tau. PS1 directly binds tau and a tau kinase, glycogen synthase kinase 3beta (GSK-3beta). Deletion studies show that both tau and GSK-3beta bind to the same region of PS1, residues 250-298, whereas the binding domain on tau is the microtubule-binding repeat region. The ability of PS1 to bring tau and GSK-3beta into close proximity suggests that PS1 may regulate the interaction of tau with GSK-3beta. Mutations in PS1 that cause Alzheimer's disease increase the ability of PS1 to bind GSK-3beta and, correspondingly, increase its tau-directed kinase activity. We propose that the increased association of GSK-3beta with mutant PS1 leads to increased phosphorylation of tau.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Brain / enzymology
  • Brain / metabolism
  • Calcium-Calmodulin-Dependent Protein Kinases / metabolism*
  • Chromatography, Affinity
  • Glycogen Synthase Kinase 3
  • Glycogen Synthase Kinases
  • Humans
  • Infant, Newborn
  • Membrane Proteins / isolation & purification
  • Membrane Proteins / metabolism*
  • Middle Aged
  • Precipitin Tests
  • Presenilin-1
  • Substrate Specificity
  • tau Proteins / metabolism*

Substances

  • Membrane Proteins
  • PSEN1 protein, human
  • Presenilin-1
  • tau Proteins
  • Glycogen Synthase Kinases
  • Calcium-Calmodulin-Dependent Protein Kinases
  • Glycogen Synthase Kinase 3